These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12084987)

  • 1. [Potential antibiotic pharmaceutical cost reduction in an operative unit of infectious diseases. Projects for making savings and improvements].
    Sabbatani S; Cesari R; Pipitone E
    Infez Med; 2001 Sep; 9(3):137-46. PubMed ID: 12084987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic management and early discharge from hospital: an economic analysis.
    Gray A; Dryden M; Charos A
    J Antimicrob Chemother; 2012 Sep; 67(9):2297-302. PubMed ID: 22623630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a Czech hospital.
    Mach R; Vlcek J; Prusova M; Batka P; Rysavy V; Kubena A
    Pharm World Sci; 2007 Oct; 29(5):565-72. PubMed ID: 17610145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
    Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods of documenting cost savings associated with an antibiotic management program.
    Lacy MK; Eidem LA; Bond JA; Swartz MA
    Pharm Pract Manag Q; 1996 Jul; 16(2):66-70. PubMed ID: 10161615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cluster randomized trial for the implementation of an antibiotic checklist based on validated quality indicators: the AB-checklist.
    van Daalen FV; Prins JM; Opmeer BC; Boermeester MA; Visser CE; van Hest RM; Hulscher ME; Geerlings SE
    BMC Infect Dis; 2015 Mar; 15():134. PubMed ID: 25888180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of formulary restriction in the use of antibiotics in an Italian hospital.
    Bassetti M; Di Biagio A; Rebesco B; Amalfitano ME; Topal J; Bassetti D
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):529-34. PubMed ID: 11699621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting.
    Ektare V; Khachatryan A; Xue M; Dunne M; Johnson K; Stephens J
    J Med Econ; 2015; 18(12):1092-101. PubMed ID: 26368787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The hospital costs for patients with human immunodeficiency virus infection].
    Rabanaque Hernández MJ; Tomás Aznar C; Gómez López LI; Aibar Remón C; Pérez de Agreda JP; Febrel Bordeje I
    Med Clin (Barc); 1992 Jan; 98(3):85-8. PubMed ID: 1552755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Geriatric Emergency Department Intervention model of care: a pragmatic trial.
    Wallis M; Marsden E; Taylor A; Craswell A; Broadbent M; Barnett A; Nguyen KH; Johnston C; Glenwright A; Crilly J
    BMC Geriatr; 2018 Dec; 18(1):297. PubMed ID: 30509204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evidence-based medicine, health costs and treatment of intra-abdominal infection].
    Badía X; Brosa M; Tellado JM
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():86-94. PubMed ID: 10605193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
    Eckmann C; Lawson W; Nathwani D; Solem CT; Stephens JM; Macahilig C; Simoneau D; Hajek P; Charbonneau C; Chambers R; Li JZ; Haider S
    Int J Antimicrob Agents; 2014 Jul; 44(1):56-64. PubMed ID: 24928311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
    Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of human immunodeficiency virus infection on the consumption of hospital resources. A correlation with the degree of immunodeficiency].
    Rovira Daudí E; González Monte C; Belda Mira A; Pascual Izuel JM; Gonzalvo Bellver F
    An Med Interna; 1999 Jan; 16(1):8-14. PubMed ID: 10089644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organisational and financial consequences of the early discharge of patients treated for acute bacterial skin and skin structure infection and osteomyelitis in infectious disease departments in Greece, Italy and Spain: a scenario analysis.
    Restelli U; Bonfanti M; Croce D; Grau S; Metallidis S; Moreno Guillén S; Pacelli V; Rizzardini G; Soro M; Vozikis A; Gray A
    BMJ Open; 2019 Sep; 9(9):e031356. PubMed ID: 31515433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic impact simulation analysis of use of tigecycline, as appropriate, in first-course antibiotic therapy for complicated intra-abdominal infections in intensive care patients.
    Ancona F
    Minerva Med; 2010 Oct; 101(5):319-28. PubMed ID: 21048554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of an infectious disease service on antibiotic prescription behavior and selection of multiresistant pathogens.
    Lemmen SW; Häfner H; Kotterik S; Lütticken R; Töpper R
    Infection; 2000; 28(6):384-7. PubMed ID: 11139159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug utilization and pharmaceutical cost-containment in germany-perspectives 1 year after enactment of the GMG].
    Schlander M
    Med Klin (Munich); 2005 Jun; 100(6):314-24. PubMed ID: 15968483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
    Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.